Member Info for Fredd1eboy

Non-dilutive funding to expand! ....Roll on Tuesday!

Good post OB...with regards to grangers........'you may be being a bit previous'…let's see what the cost is to buy back ...the shares prematurely dumped yesterday.....Could this end up a bit of a "Bear Trap"

The latest update states very clearly....Jon dillutive funding opportunities.....I sincerely hope the trolls on this site get 🔥 to their foundations

Both companies planned to pursue non-dilutive funding opportunities to support the expansion of their development projects through European grant schemes.

Hi CB based on recent events Im inclined to agree with your comment...."Fred, admit it. You really don't have a clue but neither do I tbh".

Yes.. best ignore and await recieving meat on the bone next week. Personally I'm feeling bullish, but I'm just a 'long term investor' content that Vals management team is being held to account and I'm excited for a decent investor update next week.....

Read Starmer and not Starter....dam spell correct

Listen to on playback... BBC2.. ...Excellent speech....watch this space

Or the resultant merger is looking good and who needs two financial chiefs.....

Our technology will help to enable the reduction and "REPLACEMENT of ANIMAL" testing, by providing more ACCURATE data on safety and efficacy than CURRENT pre-clinical testing models."

Ps...I may not be able to comment on any reply from your goodself as I have some other matter to deal with

Good posts Porks and I'm minded to agree with your summary of events that has led to the awful investment situation Vals previous BOD has taken uscto. However, albeit at the 12th hour we now have a professional business/scientifically managed BOD and VAL's gems awaiting exploitation for the benefit of the chronically sick and long suffering investors. As I've previously mentioned, a bit of support from you would be appreciated as things are not yet dire and personally I'm now feeling bullish. Please work with us and perhaps you may be pleasantly surprised

During last December Ambrose entered into ac12 months exclusivity agreement with Val...more recently they have advised that 401 is a good fit in their portfolio.....so all looking good for a deal within the next 3 months and we'll within vals current funding pathway....DYOR

Toby Wilson Waterworth, CEO of Ambrose Healthcare says, "We are excited to build on ValiRx's initial clinical development to bring a much-needed new treatment option to late-stage cancer patients.  VAL401 has a strong safety and clinical profile, and a novel delivery formulation. It is a good fit for the rare disease product portfolio that Ambrose is developing."

That'll do me mate....night night...and let's see what tomorrow brings us

Agreed PM there's plenty of revenue to keep us going for at the rest of the year....and plenty of news to come...Personally, I'm looking forward to GREAT THINGS yet to come from our new PROFESSIONAL Management...

Spot on Laura.....doesn't he......its 'decievingly' uncanny!

....years of research lung and pancreatic cancer....positive results in human trials....NHS ready to take further.....we will very soon find out and val, under new professional management, will come of age.

Time for Valirx to come of age...

Professional management team.

Significant shareholdings

Knowledge of the science.

Capable of closing a deal.

It's time to turn Val from a directors cash cow to an investor focussed professional business.

Time for Valirx to come of age...

Professional management team.

Significant shareholdings

Knowledge of the science.

Capable of closing a deal.

It's time to turn Val from a directors cash cow to an investor focussed professional business.